19.08

3.64% -0.72

Pre-market: 19.50 0.42 +2.20%

Staar Surgical Co (STAA)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Staar Surgical Co stock is traded at $19.08, with a volume of 880.08K. It is down -3.64% in the last 24 hours and down -17.97% over the past month. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Previous Close:

$19.80

Open:

$19.8

24h Volume:

880.08K

Relative Volume:

0.91

Market Cap:

$956.75M

Revenue:

$290.38M

Net Income/Loss:

$-21.03M

P/E Ratio:

-44.43

EPS:

-0.4294

Net Cash Flow:

$-54.99M

1W Performance:

-10.17%

1M Performance:

-17.97%

6M Performance:

+0.58%

1Y Performance:

-28.73%

1-Day Range:

$19.05

$20.08

1-Week Range:

$19.05

$21.16

52-Week Range:

$15.59

$35.87

Staar Surgical Co Stock (STAA) Company Profile

Name

Staar Surgical Co

Sector

Healthcare (1068)

Industry

Medical Instruments & Supplies (56)

Phone

(626) 303-7902

Address

1911 WALKER AVE, MONROVIA, CA

Employee

957

Twitter

@visianicl

Next Earnings Date

2026-11-04

Latest SEC Filings

STAA's Discussions on Twitter

Compare STAA vs ISRG, BDX, RMD, ALC, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STAA Staar Surgical Co	19.08	956.75M	290.38M	-21.03M	-54.99M	-0.4294
ISRG Intuitive Surgical Inc	399.52	141.14B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	179.23	48.82B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	221.89	32.01B	5.54B	1.52B	1.74B	10.37
ALC Alcon Inc	64.56	31.21B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	34.66	30.41B	29.14B	1.07B	1.05B	1.1956

Staar Surgical Co Stock (STAA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-09-26	Upgrade	Canaccord Genuity	Hold → Buy
Feb-03-26	Initiated	Wedbush	Neutral
Jan-16-26	Resumed	Morgan Stanley	Underweight
Apr-21-25	Initiated	Wells Fargo	Equal Weight
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy
Mar-11-24	Upgrade	Stifel	Hold → Buy
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy
Dec-08-22	Initiated	Stifel	Hold
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight
Oct-13-22	Initiated	Mizuho	Buy
Apr-08-22	Initiated	Needham	Buy
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy
Jul-09-21	Initiated	Oppenheimer	Perform
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold
Oct-26-20	Downgrade	Sidoti	Buy → Neutral
Aug-31-20	Upgrade	Sidoti	Neutral → Buy
Aug-06-20	Reiterated	The Benchmark Company	Buy
Jul-06-20	Downgrade	Sidoti	Buy → Neutral
Jun-24-20	Downgrade	BTIG Research	Buy → Neutral
Jun-15-20	Initiated	Jefferies	Buy
Dec-04-19	Initiated	BTIG Research	Buy
Sep-24-18	Reiterated	The Benchmark Company	Buy
Aug-06-18	Resumed	The Benchmark Company	Buy
Nov-20-17	Reiterated	The Benchmark Company	Buy
Aug-14-17	Reiterated	The Benchmark Company	Buy
Mar-03-17	Reiterated	The Benchmark Company	Buy
May-18-16	Upgrade	The Benchmark Company	Hold → Buy
Sep-10-13	Resumed	The Benchmark Company	Buy
Feb-28-13	Reiterated	The Benchmark Company	Buy
Nov-01-12	Downgrade	Canaccord Genuity	Buy → Hold
Mar-02-12	Initiated	Northland Securities	Outperform
Oct-25-11	Reiterated	The Benchmark Company	Buy
Oct-12-10	Initiated	Morgan Joseph	Buy
May-11-10	Initiated	Benchmark	Buy

View All

Staar Surgical Co Stock (STAA) Latest News

Sep 24, 2026

Why is STAAR Surgical stock climbing today? By Investing.com - Investing.com Canada

Sep 24, 2026

Is Staar Surgical Co (STAA) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus

Sep 23, 2026

STAAR Surgical Company (STAA) Stock Forecasts - finance.yahoo.com

Sep 23, 2026

STAAR Surgical Company (STAA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026

Sep 22, 2026

STAA Rated Buy by Jefferies -- Price Target Lowered to $23 - GuruFocus

Sep 22, 2026

STAAR Surgical Q2 EPS $0.16 beats $0.15 estimate; sales up 111% - scanx.trade

Sep 22, 2026

Sep 20, 2026

Cataract Surgery Devices Market Size, Share & Growth Report, 2035 - SNS Insider

Sep 20, 2026

Sep 18, 2026

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 31% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Sep 18, 2026

Sep 17, 2026

A Look at Staar Surgical Co (STAA) After 5.2% Decline -- GF Value $33.38 vs Price $21.24 - GuruFocus

Sep 17, 2026

Learn Why The Bull Case For STAAR Surgical Stock Could Change Following Earnings Rebound - simplywall.st

Sep 17, 2026

Sep 15, 2026

Is STAAR Surgical (STAA) A Bargain Following Its Profit Turnaround And China Led Sales Rebound? - simplywall.st

Sep 15, 2026

Sep 13, 2026

STAAR Surgical (STAA) Swings To Profit On China Rebound - finance.yahoo.com

Sep 13, 2026

Sep 12, 2026

STAAR Surgical (STAA) Says Implantable Lenses Are Taking Share From Laser Surgery - simplywall.st

Sep 12, 2026

Sep 11, 2026